CYP 232 (Ralix 8 mg-2.5 mg-40 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
Pill imprint CYP 232 has been identified as Ralix 8 mg-2.5 mg-40 mg.
Ralix is used in the treatment of rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Ralix 8 mg-2.5 mg-40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- chlorpheniramine/methscopolamine/phenylephrine
- Imprint:
- CYP 232
- Strength:
- 8 mg-2.5 mg-40 mg
- Color:
- White
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
- 60258-0232
More about Ralix (chlorpheniramine / methscopolamine / phenylephrine)
Consumer resources
- Other brands: Duravent DA, Extendryl Chews, Nohist Plus, DuraTan PE, More (4) »
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
